Poradosu Enrique has filed 7 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 150000 shares of Nuvectis Pharma, Inc. ($NVCT) on January 06, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | A | Common Stock | 150000 | $0.00 | 1,806,319.0000 | 21,812,716 | 9.06% | 0.69% |
| Jan. 2, 2025 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | A | Common Stock | 150000 | $0.00 | 1,656,319.0000 | 17,113,169 | 9.96% | 0.88% |
| Nov. 19, 2024 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | P | Common Stock | 2000 | $4.99 | 1,506,319.0000 | 17,230,559 | 0.13% | 0.01% |
| May 10, 2024 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | P | Common Stock | 500 | $6.29 | 1,504,319.0000 | 16,559,335 | 0.03% | 0.00% |
| Jan. 3, 2024 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | A | Common Stock | 130000 | $0.00 | 1,503,819.0000 | 15,556,655 | 9.46% | 0.84% |
| March 27, 2023 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | P | Common Stock | 500 | $11.55 | 1,373,819.0000 | 12,657,651 | 0.04% | 0.00% |
| Jan. 12, 2023 | Nuvectis Pharma, Inc. | $NVCT | Poradosu Enrique | Chief Science & Business Off | A | Common Stock | 115000 | $0.00 | 1,373,319.0000 | 12,657,651 | 9.14% | 0.91% |